Polymorphism of stress protein HSP70-2 gene in Tunisians: Susceptibility implications in type 2 diabetes and obesity

Diabetes and Metabolism

Volumn 30, Issue 2, 2004, Pages 175-180

  Bouassida, K Zouari ^a   Chouchane, L ^b   Jellouli, K ^a   Cherif S ^a   Haddad, S ^a   Gabbouj, S ^b   Danguir, J ^a  

^a Institut National de Nutrition Tunis   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Obesity; Polymorphism; Stress proteins; Tumor necrosis factor; Type 2 diabetes

Indexed keywords

CYTOKINE; GENE PRODUCT; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 2; INSULIN; ORAL ANTIDIABETIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CHROMOSOME ANALYSIS; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE MAPPING; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HSP70 2 GENE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TNF1 GENE; TNF2 GENE; TNFALPHA GENE; TUNISIA;

EID: 2642562009     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1262-3636(07)70104-0     Document Type: Article

References (36)

1. WHO obesity-preventing managing the global epidemic. WHO consultation on obesity, Geneva 3-5 June. WHO: Geneva, 19971-276.
2. Perusse L, Bouchard C. Genotype environment interaction in human obesity. Nutr Rev, 1999, 57, S31-7.
3. Comuzzie AG, Allison DB. The search for human obesity genes. Science, 1998, 280, 1374-7.
4. Fernandez-Real JM, Gutierrez C, Ricart W, et al. The TNFα gene NCOI polymorphism influences the relation ship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes, 1997, 46, 1468-72.
5. Hotamisligil GH, Spiegelman BM. Tumor necrosis factor. A key component of the obesity-diabetes link. Diabetes, 1994, 43, 1271-8.
6. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. The expression of TNF alpha by human muscle. J Clin Invest, 1996, 97, 1111-6.
7. Hotamisligil GS, Shargill NS, Spieglman BM. Adipose expression of tumor necrosis factor-α direct role in obesity-linked insulin resistance. Science, 1993, 259, 87-91.
8. Morin CL, Schlaepfer IR, Eckel RH. Tumor necrosis factor-alpha eliminates binding of NF-Y and an octamer-binding protein to the lipoprotein lipase promoter in 3T3-L1 adipocytes. J Clin Invest, 1995, 95, 1684-9.
9. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor α-in human obesity and insulin resistance. J Clin Invest, 1995, 95, 2409-15.
10. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest, 1995, 2111-9.
11. Bertin E, Nguyen P, Guenounou M, Durlach V, Potron G, Leutenegger M. Plasma levels of tumor necrosis factor-alpha (TNFα) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes and metabolism, 2000, 26, 178-82.
12. Koistinen HA, Bastard JP, Dusserre E, et al. Subcutaneous adipose tissue expression of tumor necrosis factor-α is not associated with whole body insulin resistance in obese non diabetic or in type-2 diabetic subjects. E J Clin Invest, 2000, 30, 302-10.
13. Wilson AG, Di Giovine FS, Balkemore AIF, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha (TNFα) gene detectable by Nco1 restriction of PCR product. Hum Mol Genet, 1993, 1, 353-9.
14. Wilson AG, Symons JA, Mc Dowell TL, Di Giovine FS, Duff GW. Effects of a tumor necrosis factor (TNF alpha) promotor base transition on transcriptional activity. Br J Rheumatol, 1995, 33, 89-97.
15. Sargent CA, Dunham I, Trowsdale J, Campbell RD. Human major histocompatibility complex contains genes for the major heat shock protein HSP70. Proc Natl Acad Sci, 1989, 1968-72.
16. Milner CM, Campbell RD. Structure and expression of the MHC-linked HSP70 genes. Immunogenetics, 1990, 32, 241-2.
17. Hunt C, Morimoto RI. Conserved features of eukaryotic HSP70 genes revealed by comparison with the nucleotide sequence of human HSP70. Proc Natl Acad Sci, 1985, USA 82, 6455-9.
18. Van Buskirk AM, De Nagel DC, Gualiardi LE. Cellular and subcellular distribution of PBP 72/74, a peptide-binding proteins that plays a role in antigen processing. J Immunol, 1991, 146, 500-6.
19. Ribeiro SP, Villar J, DeHoyos A, Slutsky AS. Heat stress decreases tumor necrosis factor release in LPS-stimulated alveolar macrophages. Am Rev Respir Dis, 1993, 147, A229.
20. Hall TJ. Role of HSP70 in cytokine production. Experentia, 1995, 50, 1048-53.
21. Van Molle W, Wielockx B, Mahieu T, et al. HSP70 protects against TNF-Induced inflammatory shcck. Immunity, 2002, 16, 685-95.
22. Chouchane L, Danguir J, Beii C, et al. Genetic variation in the stress protein HSP70-2 gene is highly associated with obesity. In J Obesity, 2001, 25, 462-6.
23. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor recipient matching in cadaveric transplantation. Tissue Antigens, 1992, 39, 225-35.
24. Cabrera M, Shaw MA, Sharples C, et al. Polymorphism in tumor necrosis factor genes associated with muocutaneous leishmaniasis. J Exp Med, 1995, 182, 1259-64.
25. Milner CM, Compbell RD. Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics, 1992, 36, 357-62.
26. Dyer P, Warrens A. Design and interpretation of studies of the major histocompatibility complex in disease. In: Lechler R, editor. HLA and disease. London. Academic Press, 1994, 93-121.
27. Kleinbaum N, Kupper S, Morgensten N. Principles and quantitive methodes. In: Epidemiologic research. London: Lifetime Learning Publications, 1982.
28. Dalziel B, Gosby AK, Richman RM, Bryson JM, Caterson ID. Association of the tumor necrosis factor-alpha-308 A/G promoter polymorphism with insulin resistance in obesity (Abstract). Obes Res, 2002, 10, 401-7.
29. Waltson J, Seibert M, Yen CJ, Cheskin LJ, Andersen RE. Tumor necrosis factor-α-238 and -308 polymorphisms do not associate with traits related to obesity and insulin resistance. Diabetes, 48, 2096-8.
30. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus. Results of a 25-year follow-up study. Lancet, 1992, 340, 925-9.
31. Heiimans BT, Westendorp RGJ, Droog S, Kluft C, Knook DL, Slagboom PE. Association of the tumor necrosis factor α-308G/A polymorphism with the risk of diabetes in an elderly population-based cohort. Genes and Immunity, 2002, 3, 225-8.
32. Furuta M, Yano Y, Ito K, et al. Relationship of tumor necrosis factor-alpha-308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus (Abstract). Diabetes Res Clin Pract, 2002, 56 (suppl 2), 141-5.
33. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS. Genetic variability in the TNF-α promoter is not associated with type 2 diabetes mellitus (NIDDM). Biochem Biophys Res Commun, 1995, 211, 833-9.
34. Pociot F, Ronningen KS, Nerup J. Polymorphic analysis of the human MHC-linked heat Shock protein (HSP70-2) and HSP70-hom genes in insulin-dependent diabetes mellitus (IDDM). Scand J Immunol, 1993, 38, 491-5.
35. Huang Q, Alvares K, Chu R, Bradfield CA, Reddy JK. Association of peroxisome proliferator-activated receptor and HSP72. J Biol Chem, 1994, 269, 8493-7.
36. Wu Z, Puigserver P, Spieglman BM. transcriptional activation of adipogenesis. Curr Opin Cell Biol, 1999, 11, 689-94.